Fifteen years in oncology. One new chapter.
The Milestone
Fifteen years ago, we started in market research. Along the way, oncology became a growing part of that work — screening, diagnostics, imaging — and today, it's grown into something bigger: helping shape the market access and commercial decisions behind oncology innovation.
The Shift
The ground has shifted beneath us. Precision medicine. Targeted therapies. A patient voice that demands to be heard. Diagnostics, imaging, and therapeutics no longer sit in separate silos — they converge on the same patient, the same pathway, the same decision.
We built Oncospective to meet that shift head-on.
From diagnostics to therapeutics
Oncospective is Cetas Healthcare's oncology insights practice — 15 years of diagnostics, devices, and imaging expertise, now extended into therapeutics. It's the natural next step for a practice that watched oncology's disciplines move closer together, and built the capability to serve all of them at once.
What makes us different
Most research partners specialize in one part of the oncology pathway. We work across all of them — because that's how oncology decisions get made now. Oncology expertise. Global reach. The attention of a dedicated practice.
Terri Crudup
Oncospective is led by Terri Crudup.
Terri brings more than 20 years of primary market research insights experience — and the perspective of a two-time cancer survivor and outspoken patient advocate — to clients navigating an increasingly connected oncology landscape.
Years of oncology insight
Deep industry expertise combined with lived patient perspective.